Saifuyuzu
4892.TPharmaceutical
Filed as Cyfuse Biomedical K.K. (2023-03–2026-08)
Major holders (5%+) · 2
| Holder | Stake |
|---|---|
| Shizuka Akieda | 7.31% |
| Masahiro Sanjo | 6.74% |
Each holder's own ratio from its most recent large-shareholding report.
Former and minor holders (below 5%) · 3
| SBI Ventures Two Co., Ltd. | 4.64% |
| SBI Shinsei Bank, Limited | 2.24% |
| SBI SECURITIES Co., Ltd. | 0.83% |
Ownership history · 74
| Holder | Ratio | Change |
|---|---|---|
| SBI Shinsei Bank, Limited2025-06-23 · amended | 2.69% | -0.03pp |
| SBI Ventures Two Co., Ltd.2025-06-23 · amended | 5.57% | -0.19pp |
| SBI SECURITIES Co., Ltd.2025-06-23 · amended | 17.04% | +15.53pp |
| Masahiro Sanjo2025-05-07 · amended | 6.74% | +1.26pp |
| Shizuka Akieda2025-05-07 | 8.33% | +1.45pp |
| SBI SECURITIES Co., Ltd.2025-03-13 · amended | 1.51% | -0.14pp |
| SBI Shinsei Bank, Limited2025-03-13 · amended | 2.72% | no change |
| SBI Ventures Two Co., Ltd.2025-03-13 · amended | 5.76% | -0.23pp |
| SBI SECURITIES Co., Ltd.2025-02-20 · amended | 1.65% | -0.69pp |
| SBI Shinsei Bank, Limited2025-02-20 · amended | 2.72% | -0.02pp |
| SBI Ventures Two Co., Ltd.2025-02-20 · amended | 5.99% | -0.04pp |
| SBI SECURITIES Co., Ltd.2024-09-11 · amended | 2.34% | -0.24pp |
| SBI Shinsei Bank, Limited2024-09-11 · amended | 2.74% | no change |
| SBI Ventures Two Co., Ltd.2024-09-11 · amended | 6.03% | no change |
| SBI SECURITIES Co., Ltd.2024-08-05 · amended | 2.58% | -0.58pp |
| SBI Shinsei Bank, Limited2024-08-05 · amended | 2.74% | no change |
| SBI Ventures Two Co., Ltd.2024-08-05 · amended | 6.03% | no change |
| SBI Shinsei Bank, Limited2024-07-11 · amended | 2.74% | no change |
| SBI SECURITIES Co., Ltd.2024-07-11 · amended | 3.16% | -0.06pp |
| SBI Ventures Two Co., Ltd.2024-07-11 · amended | 6.03% | no change |
Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.